NO774464L - Fremgangsmaate til fremstilling av 7xi-(alkoksykarbonyl)-6xi-alkyl/halogen-17-hydroksy-3-okso-17alfa-pregn-4-en-21-karboksylsyre gamma-lakton og tilsvarende 21-karboksylsyrer, deres salter og estere. - Google Patents

Fremgangsmaate til fremstilling av 7xi-(alkoksykarbonyl)-6xi-alkyl/halogen-17-hydroksy-3-okso-17alfa-pregn-4-en-21-karboksylsyre gamma-lakton og tilsvarende 21-karboksylsyrer, deres salter og estere.

Info

Publication number
NO774464L
NO774464L NO774464A NO774464A NO774464L NO 774464 L NO774464 L NO 774464L NO 774464 A NO774464 A NO 774464A NO 774464 A NO774464 A NO 774464A NO 774464 L NO774464 L NO 774464L
Authority
NO
Norway
Prior art keywords
compound
hydroxy
oxo
parts
carbon atoms
Prior art date
Application number
NO774464A
Other languages
English (en)
Norwegian (no)
Inventor
Richard Mathias Weier
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of NO774464L publication Critical patent/NO774464L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO774464A 1976-12-27 1977-12-27 Fremgangsmaate til fremstilling av 7xi-(alkoksykarbonyl)-6xi-alkyl/halogen-17-hydroksy-3-okso-17alfa-pregn-4-en-21-karboksylsyre gamma-lakton og tilsvarende 21-karboksylsyrer, deres salter og estere. NO774464L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/754,136 US4069219A (en) 1976-12-27 1976-12-27 7ξ-(Alkoxycarbonyl)-6ξ-alkyl/halo-17-hydroxy-3-oxo-17α-pregn-4-ene-21-carboxylic acid γ-lactones and corresponding 21-carboxylic acids, their salts, and esters

Publications (1)

Publication Number Publication Date
NO774464L true NO774464L (no) 1978-06-28

Family

ID=25033598

Family Applications (2)

Application Number Title Priority Date Filing Date
NO774464A NO774464L (no) 1976-12-27 1977-12-27 Fremgangsmaate til fremstilling av 7xi-(alkoksykarbonyl)-6xi-alkyl/halogen-17-hydroksy-3-okso-17alfa-pregn-4-en-21-karboksylsyre gamma-lakton og tilsvarende 21-karboksylsyrer, deres salter og estere.
NO820059A NO820059L (no) 1976-12-27 1982-01-11 Analogifremgangsmaate for fremstilling av terapeutisk virksomme 7ksi-(alkoksykarbonyl)-6ksi-alkyl/halogen-17-hydroksy-3-okso-17alfa-pregn-4-en-21-karboksylsyrer, deres salter og deres estere

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO820059A NO820059L (no) 1976-12-27 1982-01-11 Analogifremgangsmaate for fremstilling av terapeutisk virksomme 7ksi-(alkoksykarbonyl)-6ksi-alkyl/halogen-17-hydroksy-3-okso-17alfa-pregn-4-en-21-karboksylsyrer, deres salter og deres estere

Country Status (19)

Country Link
US (1) US4069219A (de)
JP (1) JPS5382767A (de)
AU (1) AU518862B2 (de)
BE (1) BE862365A (de)
CA (1) CA1099702A (de)
CH (6) CH637403A5 (de)
DE (1) DE2758279A1 (de)
DK (1) DK577377A (de)
FI (1) FI773936A7 (de)
FR (1) FR2375253A1 (de)
GB (1) GB1575986A (de)
IE (1) IE46128B1 (de)
IL (1) IL53692A (de)
NL (1) NL7714428A (de)
NO (2) NO774464L (de)
NZ (1) NZ186119A (de)
PT (1) PT67455B (de)
SE (1) SE7714764L (de)
ZA (1) ZA777684B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3111951A1 (de) * 1981-03-23 1982-09-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen 7(alpha)-alkoxycarbonyl-15ss-methylen-4-androstene, verfahren zu ihrer herstellung und verwendung als arzneimittel
JPS5921698A (ja) * 1982-07-22 1984-02-03 シエ−リング・アクチエンゲゼルシヤフト 17α−プレグネ−4−エン−3−オキソ−21−カルボン酸エステル、その製法およびこれを含有する抗アンドロゲン作用を有する医薬
DE3330084A1 (de) * 1983-08-17 1985-03-07 Schering AG, 1000 Berlin und 4709 Bergkamen 7(alpha)-alkoxycarbonyl-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone und deren 21-carbonsaeuresalze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
WO1997021720A2 (en) * 1995-12-11 1997-06-19 G.D. Searle And Co. Processes for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and intermediates useful therein and a general process for the epoxidation of olifinic double bonds
US8389687B2 (en) * 2000-10-23 2013-03-05 Shanbrom Technologies, Llc Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors
US7411006B2 (en) * 2000-10-23 2008-08-12 Shanbrom Technologies, Llc Enhanced production of blood clotting factors and fibrin fabric
US7297716B2 (en) * 2000-10-23 2007-11-20 Shanbrom Technologies, Llc Enhanced production of blood components, blood cells and plasma without freezing
EP1487859B1 (de) * 2002-03-22 2008-08-13 Pharmacia & Upjohn Company LLC Verfahren zur herstellung von eplerenon
US7196208B2 (en) * 2002-11-06 2007-03-27 Peter Guillaume Marie Wuts Processes for preparing 7-carboxy substituted steroids
RS20050339A (sr) * 2002-11-07 2007-08-03 Pharmacia & Upjohn Company Llc., Postupci za dobijanje c-7 supstituisanih 5-androstena
PT2527356T (pt) 2005-07-21 2018-03-26 Bayer Ip Gmbh Processo para a produção de 3-oxo-pregn-4-eno-21,17-carbolactonas através da oxidação isenta de metais de 17-(3-hidroxipropil)-3,17-diidroxiandrostanos
ES2311927T5 (es) 2005-07-21 2014-09-08 Bayer Pharma Aktiengesellschaft Proceso para la producción de 3-oxo-pregn-4-en-21,17-carbolactonas por la oxidación sin metales de 17-(3-hidroxipropil)-3,17-dihidroxiandrostanos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787940A (fr) * 1971-08-25 1973-02-26 Searle & Co Nouveaux medicaments diuretiques et hypotenseurs et procede de leur preparation
GB1368006A (en) * 1972-08-24 1974-09-25 Searle & Co 4alpha,7alpha-carbonyl-5-cyano-17-hzydroxy-3-oxo-5beta,17alpha- pregnane-21-carboxylic acid ypsilon-lactone
US3972871A (en) * 1975-09-22 1976-08-03 G. D. Searle & Co. 6β,17-Dihydroxy-7α-(lower alkoxy)carbonyl-3-oxo-17α-pregn-4-ene-21-carboxylic acid γ-lactones and congeners

Also Published As

Publication number Publication date
IE46128B1 (en) 1983-02-23
PT67455A (en) 1978-01-01
NZ186119A (en) 1979-08-31
CH637403A5 (de) 1983-07-29
CH635595A5 (de) 1983-04-15
FR2375253B1 (de) 1981-04-30
GB1575986A (en) 1980-10-01
US4069219A (en) 1978-01-17
IL53692A0 (en) 1978-03-10
PT67455B (en) 1979-05-25
CH638536A5 (de) 1983-09-30
AU3201277A (en) 1979-06-28
CH637405A5 (de) 1983-07-29
NL7714428A (nl) 1978-06-29
BE862365A (fr) 1978-06-27
IE46128L (en) 1978-06-27
SE7714764L (sv) 1978-06-28
CH637408A5 (de) 1983-07-29
NO820059L (no) 1978-06-28
JPS5382767A (en) 1978-07-21
ZA777684B (en) 1979-08-29
FI773936A7 (fi) 1978-06-28
FR2375253A1 (fr) 1978-07-21
CH637404A5 (de) 1983-07-29
AU518862B2 (en) 1981-10-22
IL53692A (en) 1982-07-30
DK577377A (da) 1978-06-28
DE2758279A1 (de) 1978-06-29
CA1099702A (en) 1981-04-21

Similar Documents

Publication Publication Date Title
Johnson et al. Steroid Total Synthesis—Hydrochrysene Approach. VII. 1 Metal-in-Ammonia Reduction of the Aromatic Nucleus. dl-Epiandrosterone and the Lumi Epimer
NO129337B (de)
NO820059L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 7ksi-(alkoksykarbonyl)-6ksi-alkyl/halogen-17-hydroksy-3-okso-17alfa-pregn-4-en-21-karboksylsyrer, deres salter og deres estere
NO157566B (no) Fremgangsmaate ved utskillelse av fettsyreestere fra en tilfoerselsblanding omfattende fettsyreestere og kolofoniumsyreestere.
Hartman et al. The Partial Degradation and Reconstitution of the “A” Ring of Estradiol1
NO128152B (de)
NO143159B (no) Fremgangsmaate for fremstilling av metylmetakrylat-alkylakrylatkopolymerer.
Johnson et al. Steroid Total Synthesis—Hydrochrysene Approach. VIII. 1 dl-3β, 11β-Dihydroxyandrostane-17-one
NO139524B (no) Analogifremgangsmaate ved fremstilling av nye d-homosteroider
US2777843A (en) Preparation of 4-pregnen-17alpha-ol-3, 20-dione
Edwards et al. Steroids. CCLXIII. 1 The Synthesis of 2-Formyl-Δ1-and-Δ1, 4-3-keto Steroids2
Eastham et al. Characterization of the products from oxidation of cholestenone with osmium tetroxide
US3483226A (en) 16-oxa and 17 - oxa - d - homoestra - 1,3,5(10)-trien-3-ols and d-nor-seco-diols corresponding,ethers and esters thereof
RU2009146C1 (ru) Способ получения производных 19-норпрогестерона
US2833792A (en) 1, 3, 17-trioxygenated androstane derivatives
US3422097A (en) 6,6-ethylene spirolactones
US3271390A (en) Sulfurenic acid and derivatives thereof
US3074977A (en) Process for the manufacture of 16-methylene corticoids and intermediates obtained therein
US3002005A (en) 7-methylprogesterone
US3088951A (en) 16-methyl derivatives of progesterone
US3684674A (en) Process for preparing 18-cyano-pregnane compounds
Pellegatat et al. A new reduction of the enone system of 18b-glycyrrhetic acid
US4104271A (en) 11β,18-EPOXY-9α-HALO-17,18-DIHYDROXY-3-OXO-17α-PREGN-4-ENE-21-CARBOXYLIC ACID γ-LACTONES AND CONGENERS
TW200525036A (en) Microbial method for hydrolysis and oxidation of androst-5-ene and pregn-5-ene steroid esters
DE1618508A1 (de) Verfahren zur Herstellung von des-A-Steroiden